Figure 2
Cumulative incidence of aGVhD (a), skin aGVhD (b), liver aGVhD (c) and GI aGVhD (d) In the subgroup of patients exposed to reduced intensity conditioning for patients with high EMP count vs. low EMP count at engraftment.
Cumulative incidence of aGVhD (a), skin aGVhD (b), liver aGVhD (c) and GI aGVhD (d) In the subgroup of patients exposed to reduced intensity conditioning for patients with high EMP count vs. low EMP count at engraftment.
